Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating metformin hydrochloride and aspirin in hormone-dependent prostate cancer that progressed after surgery or radiation; study status te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Recurrent Prostate Carcinoma, Stage I Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-02-08